Floatz logo

Pregabalin

Diabetic Neuropathy

Shandong Suncadia Medicine Co., Ltd.Small moleculePhase 4 / ApprovedActive
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
73/ 100
Competitive Position
81/ 100

Competitive context

24 Active assets in the Diabetic Neuropathy cohort.

Asset / SponsorPhaseRating
Duloxetine
Aga Khan University
Phase 4A
Gabapentin
Aziende Chimiche Riunite Angelini Francesco S.p.A
Phase 4BBB
Mirogabalin
Bangladesh Medical University
Phase 4BBB
Capsaicin
Corporacion Parc Tauli
Phase 4BBB
Lidocaine
Corporacion Parc Tauli
Phase 4BBB

View all 50 →

Same molecule, other indications

Pregabalin is also rated in:

focal epilepsyDormant
A
Indicative · Phase 4
82 / 100
View asset →
peripheral neuropathyActive
A
Indicative · Phase 4
82 / 100
View asset →
postherpetic neuralgiaActive
BBB
Indicative · Phase 4
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →